News & Views
- Occam Places Colin McCracken as Chief Executive Officer at Evonetix
- Occam Places Gary Glick as Chairman at CHARM Therapeutics
- Occam Places Juan Estupinan as Chief Financial Officer at Vestaron
- Occam Places Ryan Kelly as Chief Communications Officer at Recursion
- Occam Places Kali Stasi as SVP Clinical Development at Tenpoint Therapeutics
- Occam Places Rabia Gurses Ozden as Board Member at Adverum
- Occam Places Craig Thompson as CEO at Cerevance
- Occam Places Steve Staben as CSO at Lycia Therapeutics
- Occam Places Scott Saywell as Chief Business Officer at Herophilus
- Occam Places Elaine Sun on the Board of Dynavax
- Occam Places Richard Beckman as CMO at Adverum
- Occam Places Emily Conley on the Board of Nuvalent
- Strategic Recruiting for insitro
- Occam Places David Mullarkey as CEO at Bluestar
- Occam Places Lisa Deschamps as CEO of AviadoBio
- Occam Places Ed Koval as CBO at Geron
- Occam Places Andreas Grauer as CMO at Federation Bio
- Occam Places Gino Van Heeke as CSO at LabGenius
- Occam Places Scott Myers on the Board of Dynavax
- Occam Places David Lynch as CBO of Strateos
- Occam Places Emile Nuwaysir as CEO of Ensoma
- Occam Places Hans Bitter as SVP and Head, Data Science of MOMA Therapeutics
- Occam Places Alan Ashworth on the Board of CytomX
- Occam Places Brennan Doyle as CFO at Enko
- Occam Places Wendy Young as Executive Partner at MPM Capital
- Occam Places Jim Wang as SVP, Regulatory Affairs at Adverum
- Occam Places Sapna Srivastava on the Board of Nuvalent
- Occam Places Mike Sherman on Board of Werewolf Therapeutics
- Occam Places Chulani Karunatilake as CTO at Werewolf Therapeutics
- Occam Places Jeff Landau as CBO and Chau Cheng as VP IR at CytomX Therapeutics
- Occam Places Paul Audhya as CMO at KalVista Pharmaceuticals
- Occam Places Vatnak Vat-Ho as CBO at Ryvu Therapeutics
- Occam Places Teresa McRoberts as CFO at Triumvira Immunologics
- Occam Places Ann Taylor, CMO of AstraZeneca, on Board of Unlearn.AI
- Occam Places Wildon Farwell as CMO at Dyne Therapeutics
- Occam Places Louisa Daniels as General Counsel at Recursion
- Occam Places Tim Trost as CFO at Werewolf Therapeutics
- Occam Places Brian Goldman as SVP and Chief Computation Officer at ZebiAI
- Occam Places Annette Matthies as CBO at Elicio
- Occam Places Ramona Doyle as CMO at Recursion
- Occam Places Andrew Hall as CBO at IMV
- The Importance of CEO Leadership
- Occam Client and Alvin Shih Led Disarm Therapeutics to be Acquired By Eli Lilly
- Occam Client and Ted Ashburn Led Oncorus Launches IPO
- Emly Conley secures $50M in financing to advance Federation Bio’s microbial platform
- Occam Places Ali Fattaey as CEO of Metabomed
- Occam Places Vijay Reddy as Chief Research & Development Officer of Tmunity Therapeutics
- Occam Places Christopher Silber as Chief Medical Officer of Nocion Therapeutics
- Occam Places Ellen Lubman as Chief Business Officer of Werewolf Therapeutics
- Occam Places Michael Bailey on the Board of IMV Inc.
- Occam Places Emily Conley as CEO of Federation Bio
- BlackRock Leads $50 Million Round in Hydropanel Startup Zero Mass Water
- Occam Remains Alive and Well in the Time of COVID
- Occam Places Matthew Gall as CFO of iTeos Therapeutics
- Occam client Accent Therapeutics forms cancer therapeutics collaboration with AstraZeneca
- Variant Bio Aims to Make Use of Humanity’s Genetic Outliers
- Generation Bio tees up $125M IPO to push next-gen gene therapies
- Occam Places Terry-Ann Burrell on the Board of Recursion Pharmaceuticals
- Occam Places Don Manning as CMO of Pacira Biosciences
- Occam Places Gates Foundation Leader as CEO at Variant Bio
- Occam Places Carlos Campoy as SVP & CFO at CytomX
- Occam Places CEO at Ivenix, an F-Prime/WuXi Backed Medical Device Company
